Tonix Pharmaceuticals Holding Corp. — Director's Dealing 2021

Mar 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK: 0001430306
Period of Report: 2021-03-24

Reporting Person: LEDERMAN SETH (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-24	Common Stock, $0.001 par value	P	16733	$1.32	Acquired	135000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.001 par value	459	Indirect
Common Stock, $0.001 par value	177	Direct
Common Stock, $0.001 par value	31	Indirect
Common Stock, $0.001 par value	30	Indirect
Common Stock, $0.001 par value	30	Indirect
Common Stock, $0.001 par value	205	Indirect
Common Stock, $0.001 par value	33	Indirect
Common Stock, $0.001 par value	59	Indirect

Footnotes

F1: Reporting person may be deemed to be a control person of this entity.